Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Invested Capital: 2011-2025

Historic Invested Capital for Abeona Therapeutics (ABEO) over the last 15 years, with Sep 2025 value amounting to $180.1 million.

  • Abeona Therapeutics' Invested Capital rose 258.69% to $180.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.1 million, marking a year-over-year increase of 258.69%. This contributed to the annual value of $50.0 million for FY2024, which is 236.96% up from last year.
  • Abeona Therapeutics' Invested Capital amounted to $180.1 million in Q3 2025, which was up 6.50% from $169.1 million recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Invested Capital high stood at $180.1 million for Q3 2025, and its period low was -$8.9 million during Q1 2024.
  • Over the past 3 years, Abeona Therapeutics' median Invested Capital value was $49.5 million (recorded in 2025), while the average stood at $57.3 million.
  • Data for Abeona Therapeutics' Invested Capital shows a peak YoY increase of 707.52% (in 2024) and a maximum YoY decrease of 147.39% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' Invested Capital stood at $47.0 million in 2021, then plummeted by 43.02% to $26.8 million in 2022, then crashed by 44.60% to $14.8 million in 2023, then skyrocketed by 236.96% to $50.0 million in 2024, then surged by 258.69% to $180.1 million in 2025.
  • Its Invested Capital stands at $180.1 million for Q3 2025, versus $169.1 million for Q2 2025 and $49.5 million for Q1 2025.